Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma.
Publication
, Conference
Potti, A; Bild, A; Prince, R; Mukherjee, S; Dressman, H; Harpole, D; Kelley, M; Nevins, J
Published in: CLINICAL CANCER RESEARCH
December 15, 2005
Duke Scholars
Published In
CLINICAL CANCER RESEARCH
ISSN
1078-0432
Publication Date
December 15, 2005
Volume
11
Issue
24
Start / End Page
8997S / 8998S
Location
Philadelphia, PA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Potti, A., Bild, A., Prince, R., Mukherjee, S., Dressman, H., Harpole, D., … Nevins, J. (2005). Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma. In CLINICAL CANCER RESEARCH (Vol. 11, pp. 8997S-8998S). Philadelphia, PA: AMER ASSOC CANCER RESEARCH.
Potti, A., A. Bild, R. Prince, S. Mukherjee, H. Dressman, D. Harpole, M. Kelley, and J. Nevins. “Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma.” In CLINICAL CANCER RESEARCH, 11:8997S-8998S. AMER ASSOC CANCER RESEARCH, 2005.
Potti A, Bild A, Prince R, Mukherjee S, Dressman H, Harpole D, et al. Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma. In: CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2005. p. 8997S-8998S.
Potti, A., et al. “Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma.” CLINICAL CANCER RESEARCH, vol. 11, no. 24, AMER ASSOC CANCER RESEARCH, 2005, pp. 8997S-8998S.
Potti A, Bild A, Prince R, Mukherjee S, Dressman H, Harpole D, Kelley M, Nevins J. Gene expression models for recurrence risk prediction coupled with patterns of oncogenic pathway deregulation provide a novel therapeutic strategy for patients with non-small cell lung carcinoma. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2005. p. 8997S-8998S.
Published In
CLINICAL CANCER RESEARCH
ISSN
1078-0432
Publication Date
December 15, 2005
Volume
11
Issue
24
Start / End Page
8997S / 8998S
Location
Philadelphia, PA
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis